TBThayse R. Brüggemann

Thayse R. Brüggemann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thayse R. Brüggemann has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A new Anticalin protein for IL-23 inhibits non-type 2 allergen-driven mouse lung inflammation and airway hyperresponsiveness

    by Thayse R. Brüggemann, Nandini Krishnamoorthy, Matthias Hagner, Gabriele Matschiner, Thomas Jaquin, Luciana P. Tavares, Hong Yong Peh, Bruce D. Levy

    This is the first report of an Anticalin protein engineered to neutralize IL-23 (AcIL-23). Airway administration of AcIL-23 in mice regulated allergen-driven airway inflammation, mucous cell metaplasia, and methacholine-induced airway hyperresponsiveness. In mixed granulocytic allergic lung inflammation, immune regulation of IL-23 was broader than neutralization of either IL-17 or IL-5.


  • 15‐epi‐lipoxin A 5 promotes neutrophil exit from exudates for clearance by splenic macrophages

    by Hong Yong Peh, Robert Nshimiyimana, Thayse R. Brüggemann, Melody G. Duvall, Julie Nijmeh, Charles N. Serhan, Bruce D. Levy

    Specialized proresolving mediators (SPMs) promote local macrophage efferocytosis but excess leukocytes early in inflammation require additional leukocyte clearance mechanism for resolution. Here, neutrophil clearance mechanisms from localized acute inflammation were investigated in mouse dorsal air pouches. 15‐HEPE (15‐hydroxy‐5 Z ,8 Z ,11 Z ,13 E ,17 Z ‐eicosapentaenoic acid) levels were increased in the exudates. Activated human neutrophils converted 15‐HEPE to lipoxin A 5 (5 S ,6 R ,15 S ‐trihydroxy‐7 E ,9 E ,11 Z ,13 E ,17 Z ‐eicosapentaenoic acid), 15‐epi‐lipoxin A 5 (5 S ,6 R ,15 R ‐trihydroxy‐7 E ,9 E ,11 Z ,13 E ,17 Z ‐eicosapentaenoic acid), and resolvin E4 (RvE4; 5 S ,15 S ‐dihydroxy‐6 E ,8 Z ,11 Z ,13 E ,17 Z ‐eicosapentaenoic acid). Exogenous 15‐epi‐lipoxin A 5 , 15‐epi‐lipoxin A 4 and a structural lipoxin mimetic significantly decreased exudate neutrophils and increased local tissue macrophage efferocytosis, with comparison to naproxen. 15‐epi‐lipoxin A 5 also cleared exudate neutrophils faster than the apparent local capacity for stimulated macrophage efferocytosis, so the fate of exudate neutrophils was tracked with CD45.1 variant neutrophils. 15‐epi‐lipoxin A 5 augmented the exit of adoptively transferred neutrophils from the pouch exudate to the spleen, and significantly increased splenic SIRPa + and MARCO + macrophage efferocytosis. Together, these findings demonstrate new systemic resolution mechanisms for 15‐epi‐lipoxin A 5 and RvE4 in localized tissue inflammation, which distally engage the spleen to activate macrophage efferocytosis for the clearance of tissue exudate neutrophils.


  • Open Access

    The Maresin 1–LGR6 axis decreases respiratory syncytial virus-induced lung inflammation

    by Nandini Krishnamoorthy, Katherine H. Walker, Thayse R. Brüggemann, Luciana P. Tavares, Ethan W. Smith, Julie Nijmeh, Yan Bai, Xingbin Ai, R. Elaine Cagnina, Melody G. Duvall, et al.

    The resolution of infection is an active process with specific molecular and cellular mechanisms that temper inflammation and enhance pathogen clearance. Here, the specialized pro-resolving mediator (SPM) Maresin 1 (MaR1) inhibited respiratory syncytial virus (RSV)-induced inflammation. inlerleukin-13 production from type 2 innate lymphoid cells (ILC) and CD4 T helper type 2 cells was decreased by exogenous MaR1. In addition, MaR1 increased amphiregulin production and decreased RSV viral transcripts to promote resolution. MaR1 also promoted interferon-β production in mouse lung tissues and also in pediatric lung slices. MaR1 significantly inhibited the RSV-triggered aberrant inflammatory phenotype in FoxP3-expressing Tregs. The receptor for MaR1, leucine-rich repeat-containing G protein-coupled receptor 6 (LGR6), was constitutively expressed on Tregs. Following RSV infection, mice lacking Lgr6 had exacerbated type 2 immune responses with an increased viral burden and blunted responses to MaR1. Together, these findings have uncovered a multi-pronged protective signaling axis for MaR1–Lgr6, improving Tregs’s suppressive function and upregulating host antiviral genes resulting in decreased viral burden and pathogen-mediated inflammation, ultimately promoting restoration of airway mucosal homeostasis.


  • Top Cited Papers

    Neutrophil cytoplasts induce T H 17 differentiation and skew inflammation toward neutrophilia in severe asthma

    by Nandini Krishnamoorthy, David N. Douda, Thayse R. Brüggemann, Isabell Ricklefs, Melody G. Duvall, Raja-Elie E. Abdulnour, Kimberly Martinod, Luciana Tavares, Xiao Wang, Manuela Cernadas, et al.

    Neutrophil cytoplasts promote T H 17 inflammation.


  • Faculty Opinions recommendation of S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense.

    by Bruce Levy, Thayse Bruggemann

    Leukocyte trafficking mechanisms in response to inflammatory stimuli are critical to health and host defense. This article has identified an interesting new mechanism for innate lymphoid cell trafficking to a target organ. ILC2s were thought to be mostly tissue resident cells; however, this article shows that in response to epithelial derived cytokines such as IL-25 and IL-33, subpopulations of ILC2s are recruited to infected lungs. Lin-, ST2-, KLRG1hi inflammatory ILC2s (iILC2) are recruited from the intestine to the lungs in a sphingosine-1-phosphate-dependent manner in response to IL-25, whereas Lin-, ST2+, KLRG1int tissue naturally resident ILC2s (nILC2) are more responsive to IL-33. These important new findings increase our understanding of innate immune responses to infection and regulatory mechanisms to enhance host defense in the lungs.